Coming Soon: BactoTact©E.Coli
Since E.Coli is a major concern in healthcare and the food processing industry we developed BactoTact©E.Coli.
Our concept can detect pathogens on the spot and help provide insights into the processing environment and information related to sanitation, cleaning and product quality.
Patent Landscaping and feasibility studies have been performed on a variety of harmful bacteria and BactoTact© E.Coli development has started.
A quick-test for Escherichia Coli will be available soon.
Identifying bacterial presence ensures that immediate action can be taken in a more rapid and targeted manner. BactoTact©E.Coli detects E.Coli bacteria on the spot and help provide insights into the processing environment and information related to sanitation, cleaning and product quality.
Confirmatory data, independently collected in vitro, demonstrates the high specificity and speed of a Detact Diagnostics platform application for Escherichia Coli (E.Coli) when compared to Staphylococcus Aureus (S.Aureus) and Enterococcus Faecalis (E. Faecalis)
There is currently no good way to evaluate the level of cleanliness
Traditional microbiology methods are not suitable to be used in the healthcare settings or food processing industry because they need to be performed off-site, simply because you don’t want to incubate bacteria in the production facility itself.
The faster problem areas are identified, the cleaner and safer a production environment can become. Detecting harmful bacteria with a quick-test in an operating room or ICU, but also in the food processing industry, would reduce the likelihood of an outbreak.
E.Coli is the most common cause of bacterial infection in the blood. The following 5 resistant bacteria are key in causing hospital infections resulting in death:
- Escherichia coli (E.Coli)
- Klebsiella pneumoniae (K.Pneumoniae)
- Enterococcus faecium
- Pseudomonas aeruginosa
- Methicillin-resistant Staphylococcus aureus (MRSA)
Since E.Coli is a major concern in healthcare and the food processing industry we have started to develop BactoTact©E.Coli.